Transcription factors (TFs) interact with several other proteins in the process of transcriptional regulation. Here the authors identify 6703 and 1536 protein–protein interactions for 109 different hu...

Meet Absea at HUPO 2026 in Singapore. Explore proteome-scale recombinant proteins, heavy protein standards, antibody pairs, affinity tools for mass spectrometry, and spatial proteomics.

npj Parkinson's Disease - Machine-learning-assisted CRISPR/Cas12a biosensing for biomarker identification of neurodegenerative movement disorders

Absea develops, engineers and characterizes protein and antibody reagents with unprecedented throughput and quality. We strive to provide products, services and tools to break new ground in protein re...

NCOA4-driven ferritinophagy and GSH reprogramming underlie maslinic acid-induced ferroptosis and autophagy in breast cancer

Absea develops, engineers and characterizes protein and antibody reagents with unprecedented throughput and quality. We strive to provide products, services and tools to break new ground in protein…

A range of blood-based biomarkers have shown high specificity for Alzheimer’s disease (AD) pathophysiology with phosphorylated-tau (p-tau) being the most promising test. Here, the authors show the uti...

Immunotherapy has revolutionized cancer treatment, yet its efficacy in hepatocellular carcinoma (HCC) remains limited and the mechanisms of resistance…

Sensitive detection of low-abundance proteins is essential for early disease diagnosis, yet conventional chemiluminescent immunoassays rarely achieve …

Absea develops, engineers and characterizes protein and antibody reagents with unprecedented throughput and quality. We strive to provide products, services and tools to break new ground in protein re...

MAU2’s role in Cornelia de Lange syndrome was unclear. Here, the authors identify pathogenic MAU2 variants that disrupt NIPBL–MAU2 function, define MAU2‑specific episignatures, and show variable CdLS‑...